Panjon Standalone March 2023 Net Sales at Rs 1.30 crore, down 17.42% Y-o-Y

Panjon Standalone December 2022 Net Sales at Rs 1.37 crore, down 58.77% Y-o-Y

Panjon standalone net profit declines 40.00% in the December 2022 quarter

Panjon Standalone September 2022 Net Sales at Rs 1.93 crore, up 18.33% Y-o-Y

Panjon Standalone March 2022 Net Sales at Rs 1.58 crore, up 1.28% Y-o-Y

Panjon Standalone December 2021 Net Sales at Rs 3.33 crore, down 50.99% Y-o-Y

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

The stock has a moderate number of red flags

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Panjon Limited is engaged in the manufacturing and trading of consumer and pharmaceutical products. The Company is also engaged in manufacturing allopathic and ayurvedic formulations. The Company's segments include manufacturing and trading.

Panjon Ltd

Panjon Ltd

Scorecard

News & Opinions

Panjon Standalone March 2023 Net Sales at Rs 1.30 crore, down 17.42% Y-o-Y

Panjon Standalone December 2022 Net Sales at Rs 1.37 crore, down 58.77% Y-o-Y

Panjon standalone net profit declines 40.00% in the December 2022 quarter

Panjon Standalone September 2022 Net Sales at Rs 1.93 crore, up 18.33% Y-o-Y

Panjon Standalone September 2022 Net Sales at Rs 1.93 crore, up 18.33% Y-o-Y

Panjon Standalone March 2022 Net Sales at Rs 1.58 crore, up 1.28% Y-o-Y

Panjon Standalone December 2021 Net Sales at Rs 3.33 crore, down 50.99% Y-o-Y